Market Trends of Middle East & Africa Mammography Industry
This section covers the major market trends shaping the Middle East Mammography Market according to our research experts:
Digital Mammography Segment is Expected to Hold a Significant Market Share Over the Forecast Period
Digital mammography is a specialized and advanced form of mammography that uses digital receptors and computers instead of X-ray films to examine breast tissue for tumor presence. So far, conventional screen-film mammography (SFM) with high spatial resolution has been the preferred choice for screening programs in most countries. Digital mammography systems have a superior depiction of low-contrast objects, wider dynamic change, and improved diagnostic quality of images, especially when examining denser breasts. They also come with the added advantage of soft-copy image displays and soft-copy reading, which can be easily transferred. Thus, the rising advantages of digital mammography and the rising prevalence of breast cancer, coupled with the rising geriatric population, are expected to drive segment growth.
The rising prevalence of breast cancer, coupled with the rising geriatric population, is the major factor that is driving the adoption of digital mammography systems in the region. For instance, according to an article published by PubMed Central in March 2022, breast cancer is the most prevalent cancer among females in the Middle East, and in Qatar, breast cancer is one of the most diagnosed cancers among women. The article also stated that early detection of breast cancer is associated with decreased age-adjusted mortality rates of the disease. Thus, the rising prevalence of breast cancer and the importance of early detection of the disease are expected to boost the adoption of digital mammography systems. Moreover, as old age is often associated with breast cancer, the rising geriatric population is a key factor for segment growth.
Moreover, the rising developments by key market players and organizations in the region are also expected to boost market growth. For instance, in June 2021, Kheiron Medical Technologies distributed its Mia, or 'mammography intelligent assessment,' in the GCC region via a new partnership with Atlas Medical. It is an artificially intelligent solution for breast cancer screening. Furthermore, in January 2021, Prognica Labs, a UAE-based company, used artificial intelligence to detect masses in mammography screenings in the country. Hence, such developments will increase the adoption of digital mammography in the region.
Thus, the above-mentioned factors such as the increasing advantages of digital mammography and the rising prevalence of breast cancer, and the rising geriatric population are expected to boost the segment growth.
GCC is Expected to Hold a Significant Market Share Over the Forecast Period
The GCC region comprises Bahrain, Kuwait, Oman, Qatar, Saudi Arabia, and the United Arab Emirates. The major factors driving the growth of the market in GCC are the increasing prevalence of breast cancer, the increasing launch of technologically advanced products, the rising geriatric population, and the growing radiological procedures in the country.
For instance, according to an article published by MDPI in November 2022, it is expected that Saudi Arabia will continue to show an increase in breast cancer incidence, and long-term preventive measures and more effective screening strategies such as mammography are required to alleviate the burden of the disease. Thus, the high incidence of breast cancer in the country is expected to boost the usage of mammography procedures during the forecast period of the study.
Moreover, according to an article published by JCO Global Oncology in January 2023, breast cancer is said to be one of the most common cancers in the United Arab Emirates (UAE), and women generally had positive attitudes toward breast cancer screening in UAE, but they wanted more breast cancer awareness campaigns year-round and better access to screening.
Furthermore, the rising developments in the region by various organizations are also expected to boost the market growth in GCC. For instance, in October 2021, Abu Dhabi Health Services Company (SEHA) officially launched a new mobile mammography clinic in UAE as part of its Ambulatory Healthcare Services (AHS) partnership with EIN Healthcare and Siemens Healthineers.
Thus, the above-mentioned factors, such as the increasing prevalence of breast cancer, the increasing launch of technologically advanced products, the rising geriatric population, and the growing radiological procedures in the country, are expected to boost market growth.
